Skip to content

Erlotinib

Erlotinib (Tarceva) is a kinase inhibitor used in non-small cell lung cancer and pancreatic cancer. This page lists the one formulation available in this catalogue.

Tarceva

Non-small Cell Lung Cancer, Pancreatic Cancer

100mg

Erlotinib tablets for non-small cell lung and pancreatic cancer. It targets a protein that helps these cancers grow.

From$16.27/ tabletView

Key points

  • Erlotinib is a kinase inhibitor that blocks signals telling cancer cells to grow and divide.
  • The catalogue lists one formulation: a 100 mg tablet sold as Tarceva.
  • Tarceva is the originator brand; Cheplapharm Registration GmbH is the listed originator company.

What erlotinib is used for

Erlotinib is used in Non-small Cell Lung Cancer and Pancreatic Cancer. It belongs to the Oncology Support category and is available as a tablet.

Further reading